SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-023238
Filing Date
2022-11-08
Accepted
2022-11-08 16:17:18
Documents
14
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dnay-20221108.htm   iXBRL 8-K 57585
2 EX-99.1 dnay-ex99_1.htm EX-99.1 228915
3 GRAPHIC img69954019_0.jpg GRAPHIC 4733
  Complete submission text file 0000950170-22-023238.txt   428812

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dnay-20221108_lab.xml EX-101.LAB 14572
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dnay-20221108_pre.xml EX-101.PRE 10669
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dnay-20221108.xsd EX-101.SCH 2457
8 EXTRACTED XBRL INSTANCE DOCUMENT dnay-20221108_htm.xml XML 5111
Mailing Address 9535 WAPLES STREET SUITE 100 SAN DIEGO CA 92121
Business Address 9535 WAPLES STREET SUITE 100 SAN DIEGO CA 92121 858-228-4115
Telesis Bio Inc. (Filer) CIK: 0001850079 (see all company filings)

IRS No.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40497 | Film No.: 221369147
SIC: 3826 Laboratory Analytical Instruments